Home | Welcome to Contract Pharma   
Last Updated Sunday, May 19 2013
Print RSS Feed

Breaking News

Related Searches: Industry News •
Gorbec Opens GMP Analytical Lab in China

February 5, 2010
Gorbec Pharmaceutical Services is opening a GMP-compliant analytical lab in Yantai, China.  Read More »
Quanticate

February 5, 2010
Alison Bond, Ph.D. has been appointed to lead Quanticate’s new Pharmacovigilance Services team.   Read More »
Criterium Expands Staff in Three Countries

February 5, 2010
Criterium, Inc., a full-service CRO, has expanded its staff in the U.S., India and South Africa as part its business plan to increase capabilities, accommodate current sponsors and project deliverables, as well as conduct trials in a wider range of areas   Read More »
Financial Report: GlaxoSmithKline 4Q

February 4, 2010
Vaccine sales were up 85% to $2.4 billion with flu pre-pandemic sales accounting for $1.3 billion in the quarter.  Read More »
Financial Report: Allergan 4Q

February 4, 2010
Specialty pharmaceuticals sales were up 18% to $995 million in the quarter, and for the year sales were up 5% to $3.7 billion.   Read More »
Financial Report: Hospira 4Q

February 4, 2010
Growth in the quarter was driven by an increase in Specialty Injectable Pharmaceuticals, with sales in the Americas up 27% to $439.2 million, in Europe, Middle East & Africa, sales were $76.7 million (+21%), and in the Asia Pacific region, sales were   Read More »
Bayer HealthCare

February 4, 2010
Steve Meeker has been appointed vice president of manufacturing operations and head of U.S. operations at Bayer HealthCare’s manufacturing facility in Shawnee, KS.  Read More »
Financial Report: Pfizer 4Q

February 3, 2010
Pfizer completed its acquisition of Wyeth in the quarter. U.S. revenues were $7.4 billion in the quarter (+42%).  Read More »
Financial Report: Roche

February 3, 2010
The company achieved record sales for the year.  Read More »
Auxilium Gains Approval for Xiaflex

February 3, 2010
Auxilium Pharmaceuticals has received marketing approval from the FDA for Xiaflex (collagenase clostridium histolyticum), a first in class, orphan-designated, biologic for the treatment of adult Dupuytren's contracture patients with a palpable cord.  Read More »
CTI

February 3, 2010
Robert Patton has been appointed vice president of business development at Clinical Trial and Consulting Services (CTI).   Read More »
Catalent

February 2, 2010
Kurt Nielsen, Ph.D., has been appointed chief technology officer and senior vice president of innovation and growth at Catalent Pharma Solutions, Inc.   Read More »
Dalton Pharma Successfully Completes Inspection

February 2, 2010
Dalton Pharma Services has successfully completed its Health Canada audit and has received a 'compliant' rating for its GMP manufacturing facility.  Read More »
Abbott, Pierre Fabre Enter Cancer R&D Pact

February 2, 2010
Abbott has entered an exclusive worldwide licensing agreement with Pierre Fabre SA to develop and commercialize h224G11, a preclinical monoclonal antibody targeting the cMet receptor for the potential treatment of cancer.  Read More »
Corning, Sartorius Stedim Enter Cell Culture Product Pact

February 2, 2010
Corning, Inc. and Sartorius Stedim Biotech have entered a marketing and branding collaboration to offer a full range of cell culture products through a combined product catalogue.  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: